Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Gastroenteropancreatic or Lung Neuroendocrine Carcinoma

Clinical trial NCT03901378 · WITHDRAWN

Trial details

NCT number: NCT03901378
Sponsor: Ochsner Health System
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Carcinoma Large Cell Neuroendocrine Carcinoma of the Lung High Grade Neuroendocrine Carcinoma, Any Site

Start date: 2019-10-02
Primary completion: 2021-01-21
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.